Corrigendum: Regeneration of the cerebral cortex by direct chemical reprogramming of macrophages into neuronal cells in acute ischemic stroke

A corrigendum on

Regeneration of the cerebral cortex by direct chemical reprogramming of macrophages into neuronal cells in acute ischemic stroke

by Ninomiya, I., Koyama, A., Otsu, Y., Onodera, O., and Kanazawa, M. (2023). Front. Cell. Neurosci. 17:1225504. doi: 10.3389/fncel.2023.1225504

In the published article, a section of text was mistakenly not included in the publication. The missing section appears below:

2.2 Conversion of macrophages into neuronal cells

The conditioned media for neurodifferentiation consisted of Neurobasal (Gibco) supplemented with GlutaMAX, N2, and B27 supplements (0.5% each, Gibco), penicillin-streptomycin (Gibco), and brain-derived neurotrophic factor (BDNF) (20 ng/mL, Wako), glia-derived neurotrophic factor (GDNF) (20 ng/mL, Wako), neurotrophin-3 (NT3) (10 ng/mL, Wako), insulin-like growth factor 1 (IGF-1) (20 ng/mL, PEPROTECH), and basic fibroblast growth factor (bFGF) (20 ng/mL, Wako). Monocyte-derived macrophages were treated with the following chemical compounds: CHIR99021, 3 μM; Forskolin, 10 μM; Y-27632, 5 μM; Dorsomorphin, 2 μM; ISX-9, 3 μM; DB2313, 0.5 μM.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.